COMMUNIQUÉS West-GlobeNewswire

MediWound to Report First Quarter 2026 Financial Results
07/05/2026
MediWound to Report First Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Wednesday, May 27 th at 8:30 a.m. Eastern Time YAVNE, Israel, May 7, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global [...]
Biotech’s Next Wave May Already be in Motion
07/05/2026
Insider Bets on what may become a Brain Cancer Moonshot DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com and NeOnc Technology) - The biotech and pharma sector is entering one of its most pivotal periods [...]
Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
07/05/2026
IM8 products, including Daily Ultimate Essentials, Daily Ultimate Longevity, and The Beckham Stack, to be integrated into Inter Miami’s training facility and made available to all players NEW YORK and MIAMI, May 07, [...]
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
07/05/2026
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant [...]
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
07/05/2026
SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic [...]
ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals
07/05/2026
Renewed agreement provides streamlined access to ENvue equipment and supplies across a network of more than 90 hospitals in 17 states TYLER, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc . (NASDAQ: FEED) (“ [...]
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
07/05/2026
FDA accepted the new drug application (NDA) for ulixacaltamide in Essential Tremor with a PDUFA target action date of January 29, 2027, and the NDA for relutrigine, with priority review, in SCN2A and SCN8A developmental [...]
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
07/05/2026
ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical [...]
MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights
07/05/2026
Results from Phase 2 trial of once-weekly canvuparatide accepted for oral presentation at ENDO in June 2026 Phase 3 trial of once-weekly canvuparatide on track to initiate in Q3 2026 Appointment of Mark Soued as Chief [...]
Virbac : Déclaration d'actions et de droits de vote 04/2026
07/05/2026
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
07/05/2026
The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4. [...]
Scarlet Therapeutics Demonstrates In Vivo Survival of Lab-Grown Universal Red Blood Cells Equivalent to Donated Blood
07/05/2026
£3.2M Seed Round Closed to Accelerate Platform Development BRISTOL, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) -- Scarlet Therapeutics ("Scarlet") today announces a landmark preclinical result: its proprietary cell- [...]
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
07/05/2026
Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME designations in ON [...]
Most Vision Loss Is Preventable—20+ Eye Care, Neurology and Integrative Medicine Experts Unite for Free Global Summit This May
07/05/2026
Five-day virtual event during Healthy Vision Month in May will deliver science-based strategies for preventing vision loss and optimizing eye and brain health for patients and healthcare professionals With vision loss [...]
TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry
07/05/2026
Establishes domestic platform in advanced graphite, addressing a multi-billion-dollar end market underpinned by U.S. supply-chain reshoring and next-generation nuclear deployment TOMI Environmental Solutions, Inc. and [...]
Virbac : Declaration of the number of shares and voting rights 04/2026
07/05/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
07/05/2026
ZUG, Switzerland, May 07, 2026 (GLOBE NEWSWIRE) -- Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA [...]
Moongrade Releases Astrology App Designed to Deliver Personalized Birth Charts and Unlimited Compatibility Insights
07/05/2026
Moongrade offers personalized birth charts and unlimited love compatibility insights for deeper self-discovery NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Moongrade has launched a personalized astrology app designed to [...]
ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting
07/05/2026
Targeted polyNaut® nanovesicles (tPNVs) are ViaNautis’ proprietary, polymer-based delivery platform for oligonucleotides enabling cell ‑ specific targeting through nanobody conjugation CD8 nanobody conjugated tPNVs are [...]

Pages